Teaching the Elephant to Dance: Privatizing the FDA Review Process
Food and Drug Law Journal, Vol. 51, p. 651,1996
27 Pages Posted: 16 Nov 2009 Last revised: 2 Jun 2013
Date Written: November 9, 2009
Considers the implications of privatizing the Food and Drug Administration's (FDA) review of the safety and efficacy of medical devices and drugs. Concludes that the FDA's flaws - namely, a risk avoidance culture and autocratic style of regulation - can only be accomplished by breaking the agency's monopolization of this review function.
Keywords: FDA, food, drug, food and drug administration, privatization, privatize, drug review, medical device
Suggested Citation: Suggested Citation